RespireRx Pharmaceuticals Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
RespireRx Pharmaceuticals Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2023.
  • RespireRx Pharmaceuticals Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 18, 2023 was 276M shares, a 131% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 276M +156M +131% Aug 18, 2023 10-Q 2023-08-21
Q2 2023 157M +54.3M +52.8% May 18, 2023 10-Q 2023-05-22
Q1 2023 144M +46.4M +47.4% Apr 14, 2023 10-K 2023-04-17
Q3 2022 120M +24.7M +26% Nov 10, 2022 10-Q 2022-11-17
Q2 2022 103M +12.4M +13.7% May 18, 2022 10-Q 2022-05-23
Q1 2022 97.9M +8.4M +9.38% Mar 31, 2022 10-K 2022-04-15
Q3 2021 94.9M -213M -69.1% Nov 10, 2021 10-Q 2021-11-15
Q2 2021 90.4M +21M +30.3% Aug 5, 2021 10-Q 2021-08-16
Q1 2021 89.5M +55.8M +166% Apr 13, 2021 10-K 2021-04-15
Q4 2020 646M +642M +15861% Nov 20, 2020 10-Q 2020-11-23
Q3 2020 307M Aug 17, 2020 10-Q 2020-08-19
Q2 2020 69.4M +65.5M +1692% May 19, 2020 10-Q 2020-05-20
Q1 2020 33.7M +29.8M +770% Apr 9, 2020 10-K 2020-04-14
Q4 2019 4.05M Nov 15, 2019 10-Q 2019-11-19
Q2 2019 3.87M +749K +24% Aug 9, 2019 10-Q 2019-08-14
Q1 2019 3.87M +749K +24% Apr 11, 2019 10-K 2019-04-16
Q3 2018 3.59M +956K +36.3% Oct 14, 2018 10-Q 2018-10-15
Q2 2018 3.12M +834K +36.4% May 16, 2018 10-Q 2018-05-21
Q1 2018 3.12M +954K +44% Mar 31, 2018 10-K 2018-04-17
Q3 2017 2.63M +614K +30.4% Nov 13, 2017 10-Q 2017-11-20
Q2 2017 2.29M -654M -99.7% Aug 7, 2017 10-Q 2017-08-14
Q1 2017 2.17M -496M -99.6% Mar 27, 2017 10-K 2017-03-31
Q3 2016 2.02M -488M -99.6% Nov 4, 2016 10-Q 2016-11-15
Q2 2016 656M +242M +58.5% Aug 5, 2016 10-Q/A 2016-08-12
Q1 2016 499M +258M +107% Mar 23, 2016 10-K 2016-03-29
Q3 2015 490M +279M +133% Nov 6, 2015 10-Q 2015-11-12
Q2 2015 414M +213M +106% Jul 31, 2015 10-Q 2015-08-13
Q1 2015 240M +39.3M +19.5% Mar 24, 2015 10-K 2015-03-30
Q3 2014 210M +66.4M +46.1% Sep 30, 2014 10-Q 2015-03-09
Q2 2014 201M +57M +39.6% Jun 30, 2014 10-Q 2015-02-24
Q1 2014 201M +57M +39.6% Mar 31, 2014 10-Q 2015-02-10
Q4 2013 144M 0 0% Dec 31, 2013 10-K 2015-01-06
Q3 2013 144M -2 0% Sep 30, 2013 10-Q 2014-12-15
Q2 2013 144M -2 0% Jun 30, 2013 10-Q 2014-12-15
Q1 2013 144M +58.4M +68.2% Mar 31, 2013 10-Q 2014-11-24
Q4 2012 144M Dec 31, 2012 10-K 2014-10-14
Q3 2012 144M +58.4M +68.2% Sep 30, 2012 10-Q 2014-07-30
Q2 2012 144M +65.2M +82.7% Aug 13, 2012 10-Q 2012-08-16
Q1 2012 85.6M Mar 23, 2012 10-K 2012-03-30
Q3 2011 85.6M Nov 7, 2011 10-Q 2011-11-14
Q2 2011 78.9M Aug 8, 2011 10-Q 2011-08-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.